{"id":"W4294001741","doi":"10.1001/jamaoncol.2022.3829","title":"Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Cancer; Irinotecan; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007989455,0.0001806371,0.001297872,0.0001970426,0.0001838895,0.000005032902,0.0002402585,0.0001710011,0.004852505],"category_scores_gemma":[0.0005054429,0.0001424939,0.0002276839,0.0002289242,0.000211771,0.00004325623,0.0001598299,0.0003929534,0.00003230918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005009296,"about_ca_system_score_gemma":0.001242222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008688227,"about_ca_topic_score_gemma":0.00007447028,"domain_scores_codex":[0.9980475,0.0002436862,0.0004911909,0.0003389304,0.0003927843,0.0004859584],"domain_scores_gemma":[0.9979708,0.001050298,0.0002195666,0.0003825375,0.0002358835,0.0001409105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008274058,0.001291093,0.9000044,0.0001460781,0.001027615,0.0001212257,0.001233893,0.00001476756,0.002180535,0.00231229,0.03662018,0.04677389],"study_design_scores_gemma":[0.02033322,0.01431705,0.7072076,0.00002621683,0.0004371763,0.00009579468,0.001381245,0.0006148028,0.0004093138,0.001256555,0.2537382,0.0001828535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9667569,0.001410674,0.00005013806,0.01940481,0.0003306445,0.00161914,0.0001091885,0.00003989544,0.01027856],"genre_scores_gemma":[0.9701468,0.001269274,0.00202519,0.005554672,0.0002456406,0.002413878,0.00006932471,0.00004458189,0.01823059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2171181,"threshold_uncertainty_score":0.9960572,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04120636559404846,"score_gpt":0.3980314652659258,"score_spread":0.3568250996718773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}